UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of new composite materials based on TiN–Ni cermets during thermochemical pressing

Results in engineering, 2022-12, Vol.16, p.100724, Article 100724

2022

Volltextzugriff (PDF)

Development of composite materials based on TiN–Mo cermets during thermochemical pressing

International Journal of Lightweight Materials and Manufacture, 2023-12, Vol.6 (4), p.508-511

2023

Volltextzugriff (PDF)

Outcomes of colitis-associated dysplasia after referral from the community to a tertiary center

Gastrointestinal endoscopy, 2016-12, Vol.84 (6), p.1078-1079

2016

Volltextzugriff (PDF)

Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis

Digestive diseases and sciences, 2019-12, Vol.64 (12), p.3596-3601

2019

Volltextzugriff (PDF)

Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn’s Disease: Prospective Real-World Experience

Clinical gastroenterology and hepatology, 2023-07, Vol.21 (7), p.1913-1923.e2

2023

Volltextzugriff (PDF)

Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitis

Therapeutic advances in gastroenterology, 2023-01, Vol.16, p.17562848231184985-17562848231184985

2023

Volltextzugriff (PDF)

Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center

Digestive diseases and sciences, 2024-02, Vol.69 (2), p.579-587

2024

Volltextzugriff (PDF)

Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease

Gastrointestinal endoscopy, 2018-05, Vol.87 (5), p.1304-1309

2018

Volltextzugriff (PDF)

Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia

Clinical gastroenterology and hepatology, 2019-01, Vol.17 (1), p.205-206

2019

Volltextzugriff (PDF)

Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center

Clinical gastroenterology and hepatology, 2023-08, Vol.21 (9), p.2407-2409.e2

2023

Volltextzugriff (PDF)

1177 RISANKIZUMAB EFFECTIVENESS IN USTEKINUMAB-NAIVE AND USTEKINUMAB EXPERIENCED PATIENTS WITH CHROHN'S DISEASE: REAL WORLD DATA FROM A LARGE TERTIARY CENTER

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-281-S-281

2024

Volltextzugriff (PDF)

Sa1757 IMPACT OF UPADACITINIB ON CARDIOVASCULAR EVENTS AND ON LIPID VALUES IN OLDER INFLAMMATORY BOWEL DISEASE PATIENTS WITH CARDIOVASCULAR RISK FACTORS

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-509-S-509

2024

Volltextzugriff (PDF)

Sa1762 THE CHICAGO MESENTERIC FAT INDEX: A NOVEL SCALE FOR POINTOF-CARE INTESTINAL ULTRASOUND ASSESSMENT OF MESENTERIC FAT WRAPPING IN CROHN'S DISEASE IS RELIABLE AND PREDICTIVE OF DISEASE BEHAVIOR

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-511-S-512

2024

Volltextzugriff (PDF)

P975 Monitoring Inflammatory Bowel Disease (IBD) by intestinal ultrasound decreases time to treatment change and time to remission in comparison to conventional management: Analysis of patients with IBD on multiple IBD therapies

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1767-i1768

2024

Volltextzugriff (PDF)

P221 Intestinal ultrasound is predictive of disease relapse in asymptomatic Inflammatory Bowel Disease patients

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i554-i554

2024

Volltextzugriff (PDF)

Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia

Inflammatory bowel diseases, 2016-03, Vol.22 (3), p.631-637

2016

Volltextzugriff (PDF)

Mo1848 UPADACITINIB IS EFFECTIVE AND SAFE FOR THE TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASE: 1-YEAR PROSPECTIVE REAL-WORLD EXPERIENCE

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1141-S-1142

2024

Volltextzugriff (PDF)

S1481 Mild Hyperemia in the Absence of Bowel Wall Thickening on Intestinal Ultrasound is Associated With Clinical and Biochemical Disease Activity and Worse Disease Outcomes in Patients With Crohn’s Disease

The American journal of gastroenterology, 2024-10, Vol.119 (10S), p.S1067-S1068

2024

Volltextzugriff (PDF)

S1094 Effectiveness and Safety of Risankizumab Induction Therapy in Crohn’s Disease: Prospective Real-World Experience in a Large Tertiary Center

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S834-S834

2023

Volltextzugriff (PDF)

Mo1567: REAL WORLD EFFECTIVENESS AND SAFETY OF OZANIMOD: INITIAL RESULTS FROM A LARGE TERTIARY CENTER

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-823-S-824

2022

Volltextzugriff (PDF)

Tu1803 REAL WORLD EFFECTIVENESS AND SAFETY OF OZANIMOD: ONE-YEAR FOLLOW-UP FROM A LARGE TERTIARY CENTER

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-1135-S-1136

2023

Volltextzugriff (PDF)

Tu1784 UPADACITINIB IS EFFECTIVE AND SAFE FOR CROHN'S DISEASE: PROSPECTIVE REAL-WORLD EXPERIENCE

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-1126-S-1126

2023

Volltextzugriff (PDF)

Su1890 ULCERATIVE COLITIS PATIENTS WITH QUIESCENT OR ACTIVE HISTOLOGY HAVE REDUCED RECTAL COMPLIANCE COMPARED TO NORMALIZED HISTOLOGY OR NON-IBD CONTROLS

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-690-S-690

2020

Volltextzugriff (PDF)

P848 Risankizumab Effectiveness in Ustekinumab-naïve and Ustekinumab-experienced Patients with Crohn’s Disease- Real-world Data from a Large Tertiary Center

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1575-i1575

2024

Volltextzugriff (PDF)

Penetrating Disease, Narcotic Use, and Loop Ostomy Are Associated with Ostomy and IBD-related Complications After Ostomy Surgery in Crohn’s Disease Patients

Journal of gastrointestinal surgery, 2015-10, Vol.19 (10), p.1852-1861

2015

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(37)
Humans
(26)
Gastroenterology & Hepatology
(25)
Male
(24)
Biological And Medical Sciences
(23)
Female
(19)
Medical Sciences
(16)
Animals
(14)
Middle Aged
(14)
Adult
(12)
Rats
(12)
Fundamental And Applied Biological Sciences. Psychology
(8)
Polyethylene Glycols - Pharmacokinetics
(8)
Gastroenterology. Liver. Pancreas. Abdomen
(7)
Rats, Inbred F344
(7)
Retrospective Studies
(7)
Aged
(6)
Gastroenterology
(6)
Inflammatory Bowel Disease
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Development of new composite materials based on TiN–Ni cermets during thermochemical pressing

Development of composite materials based on TiN–Mo cermets during thermochemical pressing

Outcomes of colitis-associated dysplasia after referral from the community to a tertiary center

Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis

Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn’s Disease: Prospective Real-World Experience

Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitis

Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center

Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease

Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia

Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center

1177 RISANKIZUMAB EFFECTIVENESS IN USTEKINUMAB-NAIVE AND USTEKINUMAB EXPERIENCED PATIENTS WITH CHROHN'S DISEASE: REAL WORLD DATA FROM A LARGE TERTIARY CENTER

Sa1757 IMPACT OF UPADACITINIB ON CARDIOVASCULAR EVENTS AND ON LIPID VALUES IN OLDER INFLAMMATORY BOWEL DISEASE PATIENTS WITH CARDIOVASCULAR RISK FACTORS

Sa1762 THE CHICAGO MESENTERIC FAT INDEX: A NOVEL SCALE FOR POINTOF-CARE INTESTINAL ULTRASOUND ASSESSMENT OF MESENTERIC FAT WRAPPING IN CROHN'S DISEASE IS RELIABLE AND PREDICTIVE OF DISEASE BEHAVIOR

P975 Monitoring Inflammatory Bowel Disease (IBD) by intestinal ultrasound decreases time to treatment change and time to remission in comparison to conventional management: Analysis of patients with IBD on multiple IBD therapies

P221 Intestinal ultrasound is predictive of disease relapse in asymptomatic Inflammatory Bowel Disease patients

Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia

Mo1848 UPADACITINIB IS EFFECTIVE AND SAFE FOR THE TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASE: 1-YEAR PROSPECTIVE REAL-WORLD EXPERIENCE

S1481 Mild Hyperemia in the Absence of Bowel Wall Thickening on Intestinal Ultrasound is Associated With Clinical and Biochemical Disease Activity and Worse Disease Outcomes in Patients With Crohn’s Disease

S1094 Effectiveness and Safety of Risankizumab Induction Therapy in Crohn’s Disease: Prospective Real-World Experience in a Large Tertiary Center

Mo1567: REAL WORLD EFFECTIVENESS AND SAFETY OF OZANIMOD: INITIAL RESULTS FROM A LARGE TERTIARY CENTER

Tu1803 REAL WORLD EFFECTIVENESS AND SAFETY OF OZANIMOD: ONE-YEAR FOLLOW-UP FROM A LARGE TERTIARY CENTER

Tu1784 UPADACITINIB IS EFFECTIVE AND SAFE FOR CROHN'S DISEASE: PROSPECTIVE REAL-WORLD EXPERIENCE

Su1890 ULCERATIVE COLITIS PATIENTS WITH QUIESCENT OR ACTIVE HISTOLOGY HAVE REDUCED RECTAL COMPLIANCE COMPARED TO NORMALIZED HISTOLOGY OR NON-IBD CONTROLS

P848 Risankizumab Effectiveness in Ustekinumab-naïve and Ustekinumab-experienced Patients with Crohn’s Disease- Real-world Data from a Large Tertiary Center

Penetrating Disease, Narcotic Use, and Loop Ostomy Are Associated with Ostomy and IBD-related Complications After Ostomy Surgery in Crohn’s Disease Patients

Suchergebnisse filtern